Concerta is Johnson & Johnson's brand name for methylphenidate hydrochloride extended-release, delivered through an OROS (osmotic-release oral system) that pushes out medication steadily over about 12 hours. The FDA first approved Concerta in 2000 for attention-deficit/hyperactivity disorder in patients age 6 and older. Concerta's authorized generic, launched under a 2010 licensing settlement, first went on sale in 2011, and generic methylphenidate ER, including that authorized generic manufactured by Janssen itself, has been sold ever since. Related extended-release methylphenidate brands, such as Ritalin LA, Metadate CD, and Quillivant XR, use different delivery technology and are not interchangeable at the pharmacy counter without a new prescription.
Methylphenidate is a Schedule II controlled substance under the Controlled Substances Act, the same classification as Adderall and oxycodone. That classification drives most of the pricing quirks covered in this guide: Schedule II drugs cannot legally carry refills, are frequently excluded from flat-fee discount generic programs like Walmart's $4 list, and require either a paper prescription or a DEA-compliant electronic prescribing system for controlled substances. The Drug Enforcement Administration also sets an annual manufacturing quota for methylphenidate, and periodic tightness in that quota has contributed to regional stimulant shortages alongside the better-known Adderall shortage. Patients managing the cost of ADHD treatment while facing a pharmacy shortage can also compare generic Adderall cost, a related Schedule II stimulant with similar billing rules.
Concerta is dispensed exclusively at retail and mail-order pharmacies as a self-administered oral tablet, so it is billed through Medicare Part D rather than Part B. No HCPCS J-code applies, and there is no Medicare ASP rate to reference. Concerta was not among the first 10 drugs selected for Medicare price negotiation under the Inflation Reduction Act of 2022, so there is no negotiated Maximum Fair Price for it in 2026; pricing follows standard Part D formulary tier rules instead. Families comparing coverage across programs should also check Medicaid income limits to see whether a child or adult qualifies for near-zero copays on ADHD medication.
What Concerta Costs by Point of Pay (2026)
The price you pay depends almost entirely on WHERE you pay. The same concerta can cost many times more at a hospital than at your local pharmacy:
2026 Concerta Price by Point of Pay| Where you pay | Typical cost | Notes |
|---|
| Pharmacy counter, brand Concerta (retail, cash) | $600 - $640 / 30-day supply | 36 mg tablets; brand list price with no insurance or coupon applied |
| Pharmacy counter, generic methylphenidate ER (retail, cash) | $40 - $300 / 30-day supply | Price varies sharply by pharmacy chain; excluded from most $4 generic lists as a Schedule II drug |
| Medicare Part D (2026) | $0 - $45 / 30-day supply (plan-dependent) | Subject to the $2,100 annual out-of-pocket cap; prior authorization and quantity limits common |
| Concerta Savings Program (commercial insurance) | $4/fill, up to $150 per 30-day supply, $1,800/year cap | Ages 6-65 with commercial insurance only; not valid in California or Massachusetts |
| Medicaid | $1 - $4 / prescription | Covered in all 50 states for a documented ADHD diagnosis; prior authorization common |
Retail cash prices reflect 2026 GoodRx and SingleCare pharmacy survey data and vary by dose strength, pharmacy chain, and ZIP code. Medicare Part D costs depend on formulary tier placement.
Source: GoodRx 2026, SingleCare 2026, CMS Medicare Part D, Janssen CarePath
Why Hospitals Charge So Much
Hospital pharmacies handle Concerta and generic methylphenidate ER under the same DEA Schedule II security protocols required for amphetamines and opioids: double-locked storage, pharmacist-witnessed inventory counts, and either a paper prescription or a DEA-compliant electronic prescribing system for every dose. Maintaining that chain of custody adds real administrative overhead, which shows up as a facility markup whenever the hospital dispenses the drug rather than the patient bringing their own outpatient supply.
Concerta's inpatient billing exposure is usually modest in dollar terms because most patients take a single daily tablet and the underlying acquisition cost is low for the generic. The bigger practical issue is continuity: some hospital formularies require a psychiatry or pharmacy consult before continuing an outpatient stimulant during an unrelated admission, and a missed dose day can disrupt a patient's ADHD symptom control even though it rarely produces a large bill. Patients who spot an inflated line-item charge for Concerta or generic methylphenidate ER on a hospital bill can use the CoveredUSA Medical Bill Analyzer to check it against the National Drug Code and typical facility rates.
Patient Assistance Programs
Johnson & Johnson, through its Janssen division, runs both a commercial manufacturer coupon (the Concerta Savings Program copay card) and a separate charitable assistance program for brand Concerta. Generic methylphenidate ER manufacturers generally do not run traditional patient assistance programs because the generic is already inexpensive relative to the brand, so uninsured patients on the generic usually rely on discount coupons instead.
Patient assistance programs for Concerta| Manufacturer program | Cost / Benefit | How to apply |
|---|
| Concerta Savings Program | $4 per fill, up to $150 off each 30-day supply, for commercially insured patients ages 6 to 65; capped at $1,800 or 12 fills per year | concerta.net/coupon.html |
| Janssen CarePath (Johnson & Johnson Patient Assistance Foundation) | Free brand Concerta for uninsured or underinsured patients with household income at or below 400% of the federal poverty level | janssencarepath.com |
| Mark Cuban Cost Plus Drugs (generic methylphenidate ER) | Generic sold at manufacturer cost plus a fixed markup, often well under $40 for a 30-day supply | costplusdrugs.com |
| NeedyMeds Drug Discount Card | Variable discount accepted at most US pharmacies for generic methylphenidate ER | needymeds.org |
Manufacturer copay cards like the Concerta Savings Program are not available to anyone using Medicare, Medicaid, TRICARE, or VA benefits under federal anti-kickback law (42 U.S.C. Section 1320a-7b). If you have government-funded insurance, apply to Janssen CarePath, the income-based patient assistance program, instead.
Source: Janssen CarePath, concerta.net, NeedyMeds.org, Cost Plus Drugs
Medicare Part D
Medicare Part D plans generally place generic methylphenidate ER on Tier 1 or Tier 2 (preferred generic), while brand Concerta typically sits on a higher non-preferred brand tier with a larger copay. Most Part D plans require prior authorization or step therapy, meaning your prescriber must first document that you tried and failed on a lower-tier stimulant before the plan approves brand Concerta. Because methylphenidate is a Schedule II controlled substance, Part D plans also enforce refill-timing edits at the pharmacy, rejecting claims submitted more than a few days before the prior fill is due.
For 2026, the Medicare Part D annual out-of-pocket cap is $2,100 across all your covered Part D drugs combined. Once your true out-of-pocket spending reaches that amount in a calendar year, your plan pays 100% of your covered drug costs for the rest of the year. Concerta and generic methylphenidate ER do not carry a drug-specific monthly cap the way insulin does at $35 per month; instead, they fall entirely under the general 2026 annual cap. Adults newly diagnosed with ADHD on Medicare should also confirm their plan's formulary tier before filling, since Medicare Advantage and standalone Part D plans set tiers independently.
Common Concerta Billing Errors
Concerta and generic methylphenidate ER are oral Schedule II drugs billed only through pharmacy claims, not HCPCS J-codes. Watch for these specific billing issues:
- Brand billed when a generic or authorized generic was dispensed: Concerta's authorized generic and independently manufactured generics are not always automatically substitutable under state pharmacy law, and a mix-up can trigger a higher brand-tier copay.
- Early-refill rejection billed as a full-price new fill: Schedule II prescriptions cannot legally carry refills, and a claim submitted a few days early is often denied and then billed at the full cash price instead of being corrected as a timing issue.
- A 90-day supply split into three separate 30-day copays: federal rules adopted in 2007 let a prescriber issue sequential 30-day Schedule II prescriptions dated for future fills, but some plans still charge three separate copays instead of a lower 90-day mail-order rate.
- Prior authorization lapse billed to the patient: if the PA expires between refills, the pharmacy may dispense and bill the full retail price rather than holding the claim for a renewed authorization.
- Non-bioequivalent generic substitution: the FDA required two manufacturers, Kremers Urban and Mallinckrodt, to withdraw their generic OROS methylphenidate products between 2014 and 2016 after finding they were not bioequivalent to Concerta. Ask your pharmacist which manufacturer's generic you are receiving if symptom control changes after a refill.
Frequently Asked Questions
Is there a generic for Concerta?
Yes. Generic methylphenidate ER (OROS extended-release) has been available since 2011, when Janssen's authorized generic launched under a 2010 licensing settlement. Generic methylphenidate ER typically costs $40 to $300 for a 30-day supply in 2026, compared with $600 to $640 for the brand. Because Concerta is a small-molecule drug rather than a biologic, there is no biosimilar version, only generic equivalents.
How do I apply for the Concerta patient assistance program through Janssen CarePath?
Start at janssencarepath.com or call the Janssen CarePath support line to request the enrollment form. Your prescriber must complete a clinical section confirming your ADHD diagnosis. You will need proof of household income, proof of US residency, and proof that you lack prescription drug coverage for Concerta. Submit the completed form and documents by fax, mail, or the online portal; processing takes about 7 to 14 business days, and approved patients must reapply every 12 months.
Can I use the Concerta savings card with Medicare?
No. Federal anti-kickback law bars manufacturer copay cards, including the Concerta Savings Program, from being used by anyone enrolled in Medicare, Medicaid, TRICARE, or VA benefits. The Concerta Savings Program is limited to commercially insured patients ages 6 to 65 and caps the copay at $4 per fill, up to $150 off a 30-day supply. Medicare beneficiaries who need help affording brand Concerta should apply to Janssen CarePath, the income-based patient assistance program, instead.
What if my insurance denies coverage for Concerta?
Request the written denial notice, which will state the reason, most often step therapy or a quantity limit, and file a formal internal appeal with a letter from your prescriber documenting your ADHD diagnosis and treatment history. If the plan denies the appeal, ask your prescriber's office to request a peer-to-peer review, and escalate to an external review through your state Department of Insurance if needed. Generic methylphenidate ER or the Janssen CarePath assistance program are practical fallback options while you appeal.
Does the Inflation Reduction Act's Medicare drug price negotiation apply to Concerta?
No. Concerta was not among the first 10 drugs selected for Medicare price negotiation under the Inflation Reduction Act of 2022, so there is no negotiated Maximum Fair Price for Concerta in 2026. Pricing instead follows your Medicare Part D plan's standard formulary tier rules, and your total out-of-pocket spending across all Part D drugs is capped at $2,100 for 2026 regardless of negotiation status.
What does Concerta cost without insurance at the pharmacy counter in 2026?
Brand Concerta costs roughly $600 to $640 in cash for a 30-day supply of 36 mg tablets in 2026. Generic methylphenidate ER is far cheaper, ranging from about $40 at Kroger Rx Savings Club or $37 to $45 at CVS with a GoodRx coupon, up to $280 to $300 at pharmacies without a discount program, since Schedule II drugs are excluded from most flat-fee generic lists like Walmart's $4 program.
Do I qualify for the Janssen CarePath patient assistance program?
You generally qualify for Janssen CarePath if you are uninsured or underinsured for Concerta and your household income is at or below 400% of the federal poverty level, which is $63,840 for a household of one and $132,000 for a household of four in 2026. You also need a valid Concerta prescription, proof of US residency, and documentation that your existing coverage, if any, does not pay for Concerta.
Is generic methylphenidate ER the same as brand Concerta?
The active ingredient is the same, but not every generic manufacturer's version has been confirmed bioequivalent. The FDA required Kremers Urban and Mallinckrodt to withdraw their generic OROS methylphenidate products between 2014 and 2016 after testing showed meaningful differences from Concerta's release profile. Most generics on the market today, including Janssen's own authorized generic, are considered bioequivalent, but ask your pharmacist which manufacturer supplies your refill if you notice a change in symptom control after a switch.
